Chlamydia trachomatis infection and persistence of human papillomavirus

被引:129
作者
Silins, I
Ryd, W
Strand, A
Wadell, G
Törnberg, S
Hansson, BG
Wang, XH
Arnheim, L
Dahl, V
Bremell, D
Persson, K
Dillner, J [1 ]
Rylander, E
机构
[1] Lund Univ, Malmo Univ Hosp, Dept Med Microbiol, MAS, S-20502 Malmo, Sweden
[2] Sahlgrens Univ Hosp, Dept Pathol & Clin Cytol, S-41345 Gothenburg, Sweden
[3] Univ Uppsala Hosp, Dept Med Dermatol & Venereol, Uppsala, Sweden
[4] Umea Univ, Dept Virol, S-90187 Umea, Sweden
[5] Karolinska Hosp, Canc Screening Unit, Ctr Oncol, S-10401 Stockholm, Sweden
[6] Karolinska Inst, Huddinge Hosp, Ctr Infect Med, S-10401 Stockholm, Sweden
[7] Karolinska Inst, Danderyd Hosp, Div Gynaecol, S-10401 Stockholm, Sweden
关键词
HPV infection; HPV persistence; Chlamydia trachomatis; epidemiology;
D O I
10.1002/ijc.20970
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human papillomavirus (HPV) persistence is the major cause of cervical cancer, but most HPV infections will not persist and risk factors for HPV persistence are not well known. Chlamydia (C.) trachomatis infection seems to also be associated with cervical cancer. We investigated whether C. trachomatis infection is a risk factor for HPV persistence. In a cohort of 12,527 women participating in a population-based HPV screening trial in Sweden, 6,418 women completed testing for HPV DNA by general primer PCR and typing by reverse dot blot hybridization. On average 19 months later, 303 women that had been HPV-positive and had normal cytology at enrollment completed a new HPV test. Environmental exposures were assessed by an 87-itern questionnaire. Previous sexually transmitted infections were also investigated by serology. At follow-up, 44% of the women were positive for the same type of HPV DNA as at enrollment. Persistence correlated with length of follow-up (p < 0.01) and condom use seemed to protect against HPV persistence (p < 0.05). The most significant risk factor for persistent presence of HPV DNA was self-reported history of previous C. trachomatis infection (relative risk in multivariate model = 2.09; 95% confidence interval = 1.05-4.18). We conclude that persistence of oncogenic HPV infections is more likely among women with a previous C. trachomatis infection. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:110 / 115
页数:6
相关论文
共 35 条
  • [1] Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma
    Anttila, T
    Saikku, P
    Koskela, P
    Bloigu, A
    Dillner, J
    Ikäheimo, I
    Jellum, E
    Lehtinen, M
    Lenner, P
    Hakulinen, T
    Närvänen, A
    Pukkala, E
    Thoresen, S
    Youngman, L
    Paavonen, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (01): : 47 - 51
  • [2] DETERMINANTS OF GENITAL HUMAN PAPILLOMAVIRUS INFECTION IN LOW-RISK WOMEN IN PORTLAND, OREGON
    BAUER, HM
    HILDESHEIM, A
    SCHIFFMAN, MH
    GLASS, AG
    RUSH, BB
    SCOTT, DR
    CADELL, DM
    KURMAN, RJ
    MANOS, MM
    [J]. SEXUALLY TRANSMITTED DISEASES, 1993, 20 (05) : 274 - 278
  • [3] HLA class II alleles associated with infection by HPV16 in cervical cancer in situ
    Beskow, AH
    Josefsson, AM
    Gyllensten, UB
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (06) : 817 - 822
  • [4] HUMAN PAPILLOMAVIRUS INFECTION IS TRANSIENT IN YOUNG-WOMEN - A POPULATION-BASED COHORT STUDY
    EVANDER, M
    EDLUND, K
    GUSTAFSSON, A
    JONSSON, M
    KARLSSON, R
    RYLANDER, E
    WADELL, G
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) : 1026 - 1030
  • [5] TYPING OF HUMAN PAPILLOMAVIRUSES BY CONSENSUS POLYMERASE CHAIN-REACTION AND A NONRADIOACTIVE REVERSE DOT-BLOT HYBRIDIZATION
    FORSLUND, O
    HANSSON, BG
    BJERRE, B
    [J]. JOURNAL OF VIROLOGICAL METHODS, 1994, 49 (02) : 129 - 139
  • [6] Chlamydia trachomatis infections in female military recruits
    Gaydos, CA
    Howell, MR
    Pare, B
    Clark, KL
    Ellis, DA
    Hendrix, RM
    Gaydos, JC
    McKee, KT
    Quinn, TC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (11) : 739 - 744
  • [7] Chlamydia pneumoniae and screening for tubal factor subfertility
    Gijsen, AP
    Land, JA
    Goossens, VJ
    Leffers, P
    Bruggeman, CA
    Evers, JLH
    [J]. HUMAN REPRODUCTION, 2001, 16 (03) : 487 - 491
  • [8] Evaluation of cost-precision rations of different strategies for ELISA measurement of serum antibody levels
    Grabowska, K
    Wang, XH
    Jacobsson, A
    Dillner, J
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 271 (1-2) : 1 - 15
  • [9] SERUM ANTIBODIES AND SUBSEQUENT CERVICAL NEOPLASMS - A PROSPECTIVE-STUDY WITH 12 YEARS OF FOLLOW-UP
    HAKAMA, M
    LEHTINEN, M
    KNEKT, P
    AROMAA, A
    LEINIKKI, P
    MIETTINEN, A
    PAAVONEN, J
    PETO, R
    TEPPO, L
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1993, 137 (02) : 166 - 170
  • [10] Validity of self-reported sexually transmitted diseases among African American female adolescents participating in an HIV/STD prevention intervention trial
    Harrington, KF
    DiClemente, RJ
    Wingood, GM
    Crosby, RA
    Person, S
    Oh, MK
    Hook, EW
    [J]. SEXUALLY TRANSMITTED DISEASES, 2001, 28 (08) : 468 - 471